3-乙基庚-4-炔-3-胺 | 61822-34-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 3-乙基庚-4-炔-3-胺
• 英文名称: 1,1-Diethyl-1-(pent-2-in)-amin
• 英文别名: 1,1-diethyl-2-pentyn-1-ylamine；4-Heptyn-3-amine, 3-ethyl-；3-ethylhept-4-yn-3-amine
• CAS: 61822-34-2
• 化学式: C₉H₁₇N
• mdl: MFCD19204627
• 分子量: 139.241
• InChiKey: WKQSHYNMYBWBSE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.777
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-乙基庚-4-炔-3-胺 以100%的产率得到
  参考文献：
  名称：

  PIGEROL C.; VERNIERES J.-C.; BROLL M.; EYMARD P.; WERBENEC J.-P., EUR. J. MED. CHEM., 1977,

  摘要：

  DOI：
• 作为产物：
  描述：

  溴乙烷 、 1,1-二乙基烯丙基胺 在 氨 、 sodium 作用下， 以 乙醚 为溶剂， 以57%的产率得到3-乙基庚-4-炔-3-胺
  参考文献：
  名称：

  Active derivatives of methylamine, therapeutic compositions containing

  摘要：

  甲基胺衍生物的化学式为：##STR1##及其药用可接受的酸盐，其中R.sub.1和R.sub.3分别表示氢原子或含有1至6个碳原子的直链或支链烷基、烯基或炔基基团，R.sub.2表示含有2至7个碳原子的直链或支链烷基、烯基或炔基基团，但当R.sub.2表示化学式CH=CH--R.sub.4的烯基基团或化学式C.tbd.C--R.sub.4的炔基基团时，其中R.sub.4表示氢原子或含有1至5个碳原子的直链或支链烷基基团，R.sub.1和R.sub.3各自表示氢原子或烷基基团，R.sub.1、R.sub.2和R.sub.3使得化合物I的碳原子数不超过13个。它们可用于治疗帕金森病和纠正由神经阻滞剂引起的额外锥体外运动障碍。

  公开号：

  US04026925A1

文献信息

• Active derivatives of methylamine in therapeutic compositions and
  申请人：Labaz

  公开号：US04057644A1

  公开（公告）日：1977-11-08

  Methylamine derivatives of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein R.sub.1 and R.sub.3 each represent a hydrogen atom or a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 6 carbon atoms, R.sub.2 represents a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 2 to 7 carbon atoms with the proviso that when R.sub.2 represents an alkenyl radical of the formula CH.dbd.CH--R.sub.6 or an alkynyl radical of the formula C.tbd.C--R.sub.6, in which R.sub.6 represents a hydrogen atom or a straight- or branched-chain alkyl radical of 1 to 5 carbon atoms, R.sub.1 and R.sub.3 each represent an atom of hydrogen or an alkyl radical, R.sub.4 and R.sub.5, which are the same or different, each represent a hydrogen atom, a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 5 carbon atoms or an .omega.-hydroxyalkyl radical containing from 2 to 5 carbon atoms or R.sub.4 and R.sub.5, when they are taken together represent an alkylene radical containing from 2 to 6 carbon atoms, an alkylidene radical containing from 1 to 5 carbon atoms or the radical --CH.sub.2 --CH.sub.2 --O--CH.sub.2 --CH.sub.2 --, R.sub.1, R.sub.2 and R.sub.3 being such that the trisubstituted methylamine radical possesses no more than 13 carbon atoms. They are useful for treating Parkinson's disease and for correcting extra-pyramidal disturbances provoked by neuroleptics.

  Methylamine derivatives of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein R.sub.1 and R.sub.3 each represent a hydrogen atom or a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 6 carbon atoms, R.sub.2 represents a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 2 to 7 carbon atoms with the proviso that when R.sub.2 represents an alkenyl radical of the formula CH.dbd.CH--R.sub.6 or an alkynyl radical of the formula C.tbd.C--R.sub.6, in which R.sub.6 represents a hydrogen atom or a straight- or branched-chain alkyl radical of 1 to 5 carbon atoms, R.sub.1 and R.sub.3 each represent an atom of hydrogen or an alkyl radical, R.sub.4 and R.sub.5, which are the same or different, each represent a hydrogen atom, a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 5 carbon atoms or an .omega.-hydroxyalkyl radical containing from 2 to 5 carbon atoms or R.sub.4 and R.sub.5, when they are taken together represent an alkylene radical containing from 2 to 6 carbon atoms, an alkylidene radical containing from 1 to 5 carbon atoms or the radical --CH.sub.2 --CH.sub.2 --O--CH.sub.2 --CH.sub.2 --, R.sub.1, R.sub.2 and R.sub.3 being such that the trisubstituted methylamine radical possesses no more than 13 carbon atoms. They are useful for treating Parkinson's disease and for correcting extra-pyramidal disturbances provoked by neuroleptics.
• Active derivatives of methylamine, therapeutic compositions containing
  申请人：Labaz

  公开号：US04026925A1

  公开（公告）日：1977-05-31

  Methylamine derivatives of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein R.sub.1 and R.sub.3 each represent a hydrogen atom or a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 6 carbon atoms, R.sub.2 represents a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 2 to 7 carbon atoms with the proviso that when R.sub.2 represents an alkenyl radical of the formula CH=CH--R.sub.4 or an alkynyl radical of the formula C.tbd.C--R.sub.4, in which R.sub.4 represents a hydrogen atom or a straight- or branched-chain alkyl radical of 1 to 5 carbon atoms, R.sub.1 and R.sub.3 each represent an atom of hydrogen or an alkyl radical, R.sub.1, R.sub.2 and R.sub.3 being such that no compound of formula I possesses more than 13 carbon atoms. They are useful for treating Parkinson's disease and for correcting extra-pyramidal disturbances provoked by neuroleptics.

  甲基胺衍生物的化学式为：##STR1##及其药用可接受的酸盐，其中R.sub.1和R.sub.3分别表示氢原子或含有1至6个碳原子的直链或支链烷基、烯基或炔基基团，R.sub.2表示含有2至7个碳原子的直链或支链烷基、烯基或炔基基团，但当R.sub.2表示化学式CH=CH--R.sub.4的烯基基团或化学式C.tbd.C--R.sub.4的炔基基团时，其中R.sub.4表示氢原子或含有1至5个碳原子的直链或支链烷基基团，R.sub.1和R.sub.3各自表示氢原子或烷基基团，R.sub.1、R.sub.2和R.sub.3使得化合物I的碳原子数不超过13个。它们可用于治疗帕金森病和纠正由神经阻滞剂引起的额外锥体外运动障碍。
• Pigerol; Vernieres; Broll, European Journal of Medicinal Chemistry, 1977, vol. 12, # 4, p. 351 - 359
  作者：Pigerol、Vernieres、Broll、et al.

  DOI：——

  日期：——
• PROCESS FOR THE PURIFICATION OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST FROM RECOMBINANT E. COLI
  申请人：AVENTIS BULK S.p.A.

  公开号：EP0938501B1

  公开（公告）日：2004-07-28
• AMPHIPHILIC POLYMER AND PROCESSES OF FORMING THE SAME
  申请人：Janczewski Dominik

  公开号：US20100298504A1

  公开（公告）日：2010-11-25

  Disclosed are an amphiphilic polymer, its synthesis and uses thereof. The polymer has a hydrocarbon backbone with —COOH side groups. It further has first aliphatic moieties with a main chain of about 3 to about 20 carbon atoms and 0 to about 3 heteroatoms, and second aliphatic moieties that have a main chain of about 3 to about 80 carbon atoms and about 2 to about 40 heteroatoms. The second aliphatic moieties have a copolymerisable group. In the synthesis a maleic anhydride polymer of formula (I) where n is an integer from about 10 to about 10000 and R1 is H or methyl, is reacted with a monofunctional compound with an alkyl chain of about 3 to about 20 carbon atoms and 0 to about 2 heteroatoms, and with an at least bifunctional compound with an alkyl chain of about 3 to about 80 carbon atoms and 0 to about 40 heteroatoms. The functional group of the monofunctional compound and one functional group of the at least bifunctional compound can form a linkage with an anhydride. Another functional group of the at least bifunctional compound, which is not allowed to react with the maleic anhydride polymer, is copolymerisable.